CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-09 | LONBERG NILS Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-06-09 | Robertson Scott M. Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-06-09 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-06-09 | Bowden Christopher Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-06-09 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +23,746 | 23,746 | ||
| 2025-03-14 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +79,146 | $5.45 | $431K | 79,145 |
| 2025-03-14 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −48,526 | $12.69 | $616K | 30,620 |
| 2025-03-14 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −30,620 | $13.24 | $406K | 0 |
| 2025-03-14 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −48,720 | 107,187 | ||
| 2025-03-14 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,246 | 67,119 | ||
| 2024-09-17 | Flynn James E 10% owner | Conversion | +862,587 | 862,587 | ||
| 2024-09-17 | Flynn James E 10% owner | Conversion | +862,587 | 862,587 | ||
| 2024-09-17 | Flynn James E 10% owner | Purchase | +35,000 | $18.00 | $630K | 897,587 |
| 2024-09-17 | Flynn James E 10% owner | Purchase | +35,000 | $18.00 | $630K | 897,587 |
| 2024-09-17 | Flynn James E 10% owner | Conversion · Series C Preferred Stock | −7,973,325 | 0 | ||
| 2024-09-17 | Flynn James E 10% owner | Conversion · Series C Preferred Stock | −7,973,325 | 0 | ||
| 2024-09-16 | TPG GP A, LLC Former 10% Owner | Conversion | +1,960,425 | 1,960,425 | ||
| 2024-09-16 | TPG GP A, LLC Former 10% Owner | Conversion · Series C Preferred Stock | −18,121,194 | 0 | ||
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +2,622,898 | 2,622,898 | ||
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +2,500,095 | 2,500,095 |
Page 12 of 14 · 276 trades